UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

An Evaluation of Long-term Survival From Time of Diagnosis in Pulmonary Arterial Hypertension From the REVEAL Registry

Chest, 2012-08, Vol.142 (2), p.448-456

2012

Volltextzugriff (PDF)

Updated Treatment Algorithm of Pulmonary Arterial Hypertension

Journal of the American College of Cardiology, 2013-12, Vol.62 (25), p.D60-D72

2013

Volltextzugriff (PDF)

The REVEAL Registry Risk Score Calculator in Patients Newly Diagnosed With Pulmonary Arterial Hypertension

Chest, 2012-02, Vol.141 (2), p.354-362

2012

Volltextzugriff (PDF)

Long-Term Ambrisentan Therapy for the Treatment of Pulmonary Arterial Hypertension

Journal of the American College of Cardiology, 2009-11, Vol.54 (21), p.1971-1981

2009

Volltextzugriff (PDF)

Right Ventricular Strain for Prediction of Survival in Patients With Pulmonary Arterial Hypertension

Chest, 2011-06, Vol.139 (6), p.1299-1309

2011

Volltextzugriff (PDF)

Sex Differences in the Diagnosis, Treatment, and Outcome of Patients With Pulmonary Arterial Hypertension Enrolled in the Registry to Evaluate Early and Long-term Pulmonary Arterial Hypertension Disease Management

Chest, 2012-02, Vol.141 (2), p.363-373

2012

Volltextzugriff (PDF)

Relationship of Pulmonary Arterial Capacitance and Mortality in Idiopathic Pulmonary Arterial Hypertension

Journal of the American College of Cardiology, 2006-02, Vol.47 (4), p.799-803

2006

Volltextzugriff (PDF)

Integration of Clinical and Hemodynamic Parameters in the Prediction of Long-term Survival in Patients With Pulmonary Arterial Hypertension

Chest, 2011-06, Vol.139 (6), p.1285-1293

2011

Volltextzugriff (PDF)

Pulmonary Hypertension: Diagnosis and Management

Mayo Clinic proceedings, 2009-02, Vol.84 (2), p.191-207

2009

Volltextzugriff (PDF)

Ambrisentan Therapy in Patients With Pulmonary Arterial Hypertension Who Discontinued Bosentan or Sitaxsentan Due to Liver Function Test Abnormalities

Chest, 2009-01, Vol.135 (1), p.122-129

2009

Volltextzugriff (PDF)

Symptom burden, quality of life, and attitudes toward palliative care in patients with pulmonary arterial hypertension: Results from a cross-sectional patient survey

The Journal of heart and lung transplantation, 2012-10, Vol.31 (10), p.1102-1108

2012

Volltextzugriff (PDF)

Pulmonary arterial hypertension

Circulation (New York, N.Y.), 2006-09, Vol.114 (13), p.1417-1431

2006

Volltextzugriff (PDF)

Longterm survival among patients with scleroderma-associated pulmonary arterial hypertension treated with intravenous epoprostenol

Journal of rheumatology, 2009-10, Vol.36 (10), p.2244-2249

2009

Volltextzugriff (PDF)

Comparison of Body Habitus in Patients With Pulmonary Arterial Hypertension Enrolled in the Registry to Evaluate Early and Long-term PAH Disease Management With Normative Values From the National Health and Nutrition Examination Survey

Mayo Clinic proceedings, 2011-02, Vol.86 (2), p.105-112

2011

Volltextzugriff (PDF)

Pulmonary Arterial Hypertension: Epidemiology and Registries

Journal of the American College of Cardiology, 2013-12, Vol.62 (25), p.D51-D59

2013

Volltextzugriff (PDF)

Portopulmonary Hypertension: A Report From the US-Based REVEAL Registry

Chest, 2012-04, Vol.141 (4), p.906-915

2012

Volltextzugriff (PDF)

Predicting Survival in Pulmonary Arterial Hypertension: Insights From the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL)

Circulation (New York, N.Y.), 2010-07, Vol.122 (2), p.164-172

2010

Volltextzugriff (PDF)

Survival in Childhood Pulmonary Arterial Hypertension: Insights From the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management

Circulation (New York, N.Y.), 2012-01, Vol.125 (1), p.113-122

2012

Volltextzugriff (PDF)

Pulmonary Arterial Hypertension: Baseline Characteristics From the REVEAL Registry

Chest, 2010-02, Vol.137 (2), p.376-387

2010

Volltextzugriff (PDF)

Impact of pulmonary hypertension on the outcomes of noncardiac surgery : Predictors of perioperative morbidity and mortality

Journal of the American College of Cardiology, 2005-05, Vol.45 (10), p.1691-1699

2005

Volltextzugriff (PDF)

The Changing Picture of Patients With Pulmonary Arterial Hypertension in the United States: How REVEAL Differs From Historic and Non-US Contemporary Registries

Chest, 2011, Vol.139 (1), p.128-137

2011

Volltextzugriff (PDF)

Delay in Recognition of Pulmonary Arterial Hypertension: Factors Identified From the REVEAL Registry

Chest, 2011-07, Vol.140 (1), p.19-26

2011

Volltextzugriff (PDF)

Ambrisentan Therapy for Pulmonary Arterial Hypertension

Journal of the American College of Cardiology, 2005-08, Vol.46 (3), p.529-535

2005

Volltextzugriff (PDF)

Continuous Hemodynamic Monitoring in Patients With Pulmonary Arterial Hypertension

The Journal of heart and lung transplantation, 2008-07, Vol.27 (7), p.780-788

2008

Volltextzugriff (PDF)

Design of the REVEAL Registry for US Patients With Pulmonary Arterial Hypertension

Mayo Clinic proceedings, 2008-08, Vol.83 (8), p.923-931

2008

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Aktive Filter

ThemaPneumology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(36)

Sprache

Englisch
(36)
Japanisch
(4)

Erscheinungsjahr

n.n

Kollektion

MEDLINE
(35)
Ingenta
(35)
EZB Electronic Journals Library
(32)
Journals@Ovid
(25)
IngentaConnect Journals
(19)
NUS Single-Journal Subscriptions
(14)
Elsevier ScienceDirect Journals Complete
(10)

2 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

3 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

An Evaluation of Long-term Survival From Time of Diagnosis in Pulmonary Arterial Hypertension From the REVEAL Registry

Updated Treatment Algorithm of Pulmonary Arterial Hypertension

The REVEAL Registry Risk Score Calculator in Patients Newly Diagnosed With Pulmonary Arterial Hypertension

Long-Term Ambrisentan Therapy for the Treatment of Pulmonary Arterial Hypertension

Right Ventricular Strain for Prediction of Survival in Patients With Pulmonary Arterial Hypertension

Sex Differences in the Diagnosis, Treatment, and Outcome of Patients With Pulmonary Arterial Hypertension Enrolled in the Registry to Evaluate Early and Long-term Pulmonary Arterial Hypertension Disease Management

Relationship of Pulmonary Arterial Capacitance and Mortality in Idiopathic Pulmonary Arterial Hypertension

Integration of Clinical and Hemodynamic Parameters in the Prediction of Long-term Survival in Patients With Pulmonary Arterial Hypertension

Pulmonary Hypertension: Diagnosis and Management

Ambrisentan Therapy in Patients With Pulmonary Arterial Hypertension Who Discontinued Bosentan or Sitaxsentan Due to Liver Function Test Abnormalities

Symptom burden, quality of life, and attitudes toward palliative care in patients with pulmonary arterial hypertension: Results from a cross-sectional patient survey

Pulmonary arterial hypertension

Longterm survival among patients with scleroderma-associated pulmonary arterial hypertension treated with intravenous epoprostenol

Comparison of Body Habitus in Patients With Pulmonary Arterial Hypertension Enrolled in the Registry to Evaluate Early and Long-term PAH Disease Management With Normative Values From the National Health and Nutrition Examination Survey

Pulmonary Arterial Hypertension: Epidemiology and Registries

Portopulmonary Hypertension: A Report From the US-Based REVEAL Registry

Predicting Survival in Pulmonary Arterial Hypertension: Insights From the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL)

Survival in Childhood Pulmonary Arterial Hypertension: Insights From the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management

Pulmonary Arterial Hypertension: Baseline Characteristics From the REVEAL Registry

Impact of pulmonary hypertension on the outcomes of noncardiac surgery : Predictors of perioperative morbidity and mortality

The Changing Picture of Patients With Pulmonary Arterial Hypertension in the United States: How REVEAL Differs From Historic and Non-US Contemporary Registries

Delay in Recognition of Pulmonary Arterial Hypertension: Factors Identified From the REVEAL Registry

Ambrisentan Therapy for Pulmonary Arterial Hypertension

Continuous Hemodynamic Monitoring in Patients With Pulmonary Arterial Hypertension

Design of the REVEAL Registry for US Patients With Pulmonary Arterial Hypertension

Aktive Filter

Suchergebnisse filtern